SUZAN FENSTERMACHER: Open Payments
NPI 1023203247 · CORNING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,406 in 66 payments from 12 companies in 2025. Trend: 2023 $1,110 · 2024 $1,329 · 2025 $1,406
Food & beverage: $1,406
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $298 |
| GlaxoSmithKline, LLC. | 16 | $234 |
| GENZYME CORPORATION | 9 | $186 |
| Regeneron Healthcare Solutions, Inc. | 5 | $120 |
| Amgen Inc. | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $80 |
| Lilly USA, LLC | 3 | $80 |
| BioCryst US Sales Co., LLC | 3 | $78 |
| PFIZER INC. | 2 | $48 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, NUCALA, CUVITRU, EBGLYSS, Xolair, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
